{"id":"cohort-1-ctap101-capsules-90-g","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"5-10%","effect":"Headache"},{"rate":"5-10%","effect":"Injection site reaction"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"CTAP101 works by mimicking the action of PTHrP, which is involved in bone metabolism. By stimulating osteoblast activity and inhibiting osteoclast activity, CTAP101 aims to increase bone density and reduce the risk of fractures in patients with osteoporosis.","oneSentence":"CTAP101 is a recombinant human parathyroid hormone-related protein (PTHrP) analogue.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:27:04.523Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of osteoporosis in postmenopausal women"}]},"trialDetails":[{"nctId":"NCT01219855","phase":"PHASE2, PHASE3","title":"Safety/Efficacy Study of CTAP101 in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism (SHPT)","status":"COMPLETED","sponsor":"OPKO Health, Inc.","startDate":"2010-10","conditions":"Chronic Kidney Disease, Secondary Hyperparathyroidism, Vitamin D Insufficiency","enrollment":78}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"Cohort 1 CTAP101 Capsules - 90µg","genericName":"Cohort 1 CTAP101 Capsules - 90µg","companyName":"OPKO Health, Inc.","companyId":"opko-health-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"CTAP101 is a recombinant human parathyroid hormone-related protein (PTHrP) analogue. Used for Treatment of osteoporosis in postmenopausal women.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}